European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.
van den Berg, E
AffiliationGenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK
MetadataShow full item record
AbstractCytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray analyses have become increasingly important in the clinical management of patients with haematological neoplasms. The widespread implementation of these techniques in genetic diagnostics has highlighted the need for guidance on the essential criteria to follow when providing cytogenomic testing, regardless of choice of methodology. These recommendations provide an updated, practical and easily available document that will assist laboratories in the choice of testing and methodology enabling them to operate within acceptable standards and maintain a quality service.
CitationRack KA, van den Berg E, Haferlach C, Beverloo HB, Costa D, Espinet B, et al. European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms. Leukemia. 2019 Jan 29.
- The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
- Authors: Lee DY, Cho HI, Kang YH, Yun SS, Park SY, Lee YS, Kim Y, Lee DS
- Issue date: 2004 Jul 1
- A comparative analysis of FISH, RT-PCR, and cytogenetics for the diagnosis of bcr-abl-positive leukemias.
- Authors: Cox MC, Maffei L, Buffolino S, Del Poeta G, Venditti A, Cantonetti M, Aronica G, Aquilina P, Masi M, Amadori S
- Issue date: 1998 Jan
- Fluorescence in situ hybridization in leukemias: 'the FISH are spawning!'.
- Authors: Bentz M, Döhner H, Cabot G, Lichter P
- Issue date: 1994 Sep
- Therapeutic epigenetics: an emerging clinical approach to hematologic malignancies.
- Issue date: 2005 Mar
- Retrospective evaluation of the clinical and laboratory data from 300 patients of various hematological malignancies with chromosome 3 abnormalities.
- Authors: Liu D, Zhang Y, Chen S, Pan J, He X, Liang J, Chen Z
- Issue date: 2015 Jun